Preface |
|
xiii | |
How to Use This Book |
|
xiv | |
Note from the Authors |
|
xvii | |
Acknowledgments |
|
xviii | |
|
Chapter 1 Introduction to Patient Assessment |
|
|
1 | (24) |
|
|
|
|
2 | (1) |
|
Introduction to Patient Assessment |
|
|
2 | (1) |
|
Rationale for Patient Assessment |
|
|
3 | (1) |
|
Factors That Affect Health |
|
|
3 | (1) |
|
|
4 | (1) |
|
Cost, Access, and Quality |
|
|
4 | (3) |
|
Misallocation of Respiratory Care |
|
|
7 | (1) |
|
Optimizing Patient Outcomes |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
Grades of Recommendations for Therapy |
|
|
8 | (2) |
|
Critical Diagnostic Thinking in Respiratory Care |
|
|
10 | (1) |
|
Approach to Hypothesis Formulation and Evaluation |
|
|
10 | (8) |
|
Typical Presentations of Common Respiratory Disorders |
|
|
18 | (4) |
|
|
22 | (1) |
|
|
22 | (1) |
|
|
23 | (2) |
|
Chapter 2 Development and Implementation of Respiratory Care Plans |
|
|
25 | (44) |
|
|
|
|
26 | (1) |
|
Introduction to Respiratory Care Plans |
|
|
26 | (1) |
|
Common Conditions Requiring Respiratory Care Plan Development |
|
|
26 | (1) |
|
|
27 | (1) |
|
Respiratory Care Plan Development |
|
|
28 | (3) |
|
Goals of Respiratory Care Plans |
|
|
31 | (1) |
|
Key Elements of a Respiratory Care Plan |
|
|
31 | (1) |
|
Maintain Adequate Tissue Oxygenation |
|
|
31 | (6) |
|
Treat and/or Prevent Bronchospasm and Mucosal Edema |
|
|
37 | (1) |
|
|
37 | (2) |
|
Respiratory Care Plans for Asthma |
|
|
39 | (2) |
|
Assessment and Treatment of COPD |
|
|
41 | (3) |
|
|
44 | (1) |
|
Respiratory Care Plans for COPD |
|
|
45 | (6) |
|
Anti-inflammatory Agents and Antiasthmatic Medications |
|
|
51 | (1) |
|
Treatment of Upper Airway Inflammation |
|
|
52 | (1) |
|
Mobilize and Remove Secretions |
|
|
52 | (1) |
|
Techniques to Mobilize Secretions |
|
|
53 | (5) |
|
Provide Lung Expansion Therapy |
|
|
58 | (1) |
|
Critical Care and Mechanical Ventilation |
|
|
59 | (1) |
|
|
60 | (1) |
|
Respiratory Care Plan Format |
|
|
60 | (1) |
|
|
60 | (6) |
|
|
66 | (1) |
|
|
67 | (2) |
|
Chapter 3 Review of the Medical Record |
|
|
69 | (30) |
|
|
|
|
Introduction to Medical Records |
|
|
70 | (1) |
|
Types and Components of the Medical Record |
|
|
70 | (1) |
|
|
71 | (1) |
|
Problem-Oriented Medical Records |
|
|
72 | (4) |
|
Review of the Medical Record |
|
|
76 | (1) |
|
|
76 | (1) |
|
Admitting Diagnosis and/or Problem List |
|
|
77 | (1) |
|
|
77 | (3) |
|
Results of the History and Physical Examination(s) |
|
|
80 | (1) |
|
|
81 | (1) |
|
Progress Notes and Reports of Procedures |
|
|
81 | (1) |
|
|
81 | (1) |
|
|
82 | (1) |
|
Respiratory Care-Related Diagnostic Studies |
|
|
82 | (1) |
|
|
82 | (1) |
|
|
82 | (1) |
|
Respiratory Care Plan Development |
|
|
82 | (1) |
|
|
82 | (14) |
|
|
96 | (1) |
|
|
96 | (1) |
|
|
97 | (2) |
|
Chapter 4 Patient History |
|
|
99 | (52) |
|
|
|
|
100 | (1) |
|
Patient Interview Guidelines |
|
|
100 | (1) |
|
Demographic Data and Patient Profile |
|
|
101 | (1) |
|
|
102 | (1) |
|
History of the Present Illness |
|
|
102 | (1) |
|
Cough and Sputum Production |
|
|
103 | (1) |
|
|
103 | (2) |
|
|
105 | (4) |
|
|
109 | (1) |
|
Life-Threatening Hemoptysis |
|
|
110 | (1) |
|
Whistling, Wheezing, and Chest Tightness |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
113 | (1) |
|
Musculoskeletal Chest Pain |
|
|
113 | (1) |
|
Onset, Duration, and Timing of Chest Pain |
|
|
113 | (1) |
|
|
114 | (1) |
|
Quantification of Dyspnea |
|
|
115 | (3) |
|
|
118 | (1) |
|
|
119 | (1) |
|
|
120 | (6) |
|
|
126 | (3) |
|
Personal and Social History |
|
|
129 | (1) |
|
|
129 | (2) |
|
|
131 | (2) |
|
|
133 | (4) |
|
|
137 | (1) |
|
Inhalation of Illicit Drugs |
|
|
137 | (1) |
|
Occupational and Environmental History |
|
|
138 | (1) |
|
|
138 | (2) |
|
|
140 | (1) |
|
|
141 | (1) |
|
|
141 | (1) |
|
|
142 | (1) |
|
|
142 | (1) |
|
|
142 | (1) |
|
The Patient's Learning Needs |
|
|
142 | (1) |
|
Health-Related Quality of Life Questionnaires |
|
|
143 | (1) |
|
COVID-19 and Patient History |
|
|
144 | (1) |
|
|
144 | (1) |
|
Timing of Signs and Symptoms |
|
|
145 | (1) |
|
|
146 | (1) |
|
|
146 | (1) |
|
|
147 | (4) |
|
Chapter 5 Physical Assessment |
|
|
151 | (52) |
|
|
|
|
|
152 | (1) |
|
Introduction to the Physical Examination |
|
|
152 | (1) |
|
|
152 | (2) |
|
|
154 | (1) |
|
Order of the Physical Examination |
|
|
155 | (1) |
|
|
155 | (1) |
|
|
155 | (4) |
|
|
159 | (1) |
|
|
160 | (1) |
|
|
161 | (2) |
|
|
163 | (4) |
|
|
167 | (1) |
|
|
168 | (2) |
|
|
170 | (1) |
|
|
171 | (1) |
|
|
172 | (1) |
|
Mental Status and Neurologic Examination |
|
|
173 | (1) |
|
Assessment of Mental Status and Level of Consciousness |
|
|
173 | (4) |
|
|
177 | (3) |
|
Head, Eyes, Ears, Nose, and Throat Examination |
|
|
180 | (1) |
|
Inspection of the Head and Neck |
|
|
181 | (1) |
|
|
182 | (1) |
|
|
182 | (4) |
|
|
186 | (1) |
|
|
187 | (1) |
|
|
188 | (3) |
|
|
191 | (1) |
|
|
191 | (1) |
|
Auscultation of the Heart |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
193 | (1) |
|
|
194 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
196 | (1) |
|
|
196 | (1) |
|
|
197 | (1) |
|
Ancillary Equipment in Use |
|
|
197 | (1) |
|
|
197 | (2) |
|
|
199 | (1) |
|
|
200 | (3) |
|
Chapter 6 Assessment of Oxygenation |
|
|
203 | (52) |
|
|
|
204 | (1) |
|
|
204 | (1) |
|
Initial Assessment of Oxygenation |
|
|
204 | (4) |
|
|
208 | (1) |
|
|
208 | (1) |
|
|
208 | (1) |
|
|
209 | (2) |
|
Other Forms of Ambient Hypoxia |
|
|
211 | (1) |
|
Ventilation and the Conducting Airways |
|
|
211 | (1) |
|
|
211 | (3) |
|
|
214 | (5) |
|
Matching of Gas and Blood |
|
|
219 | (1) |
|
Alveolar Versus Arterial Oxygen Levels |
|
|
219 | (1) |
|
Ventilation-Perfusion Relationships |
|
|
220 | (6) |
|
|
226 | (3) |
|
|
229 | (1) |
|
Hemoglobin and Oxygen Content (Cao2) |
|
|
229 | (5) |
|
|
234 | (4) |
|
|
238 | (1) |
|
|
238 | (1) |
|
|
238 | (3) |
|
Uptake and Utilization of Oxygen in Tissues |
|
|
241 | (1) |
|
|
241 | (1) |
|
Tissue Uptake and Utilization |
|
|
242 | (1) |
|
Mixed Venous Oxygen Levels and the Fick Equation |
|
|
243 | (1) |
|
Overall Assessment of Oxygenation |
|
|
244 | (2) |
|
|
246 | (5) |
|
|
251 | (1) |
|
|
251 | (1) |
|
|
252 | (3) |
|
Chapter 7 Assessment of Ventilation |
|
|
255 | (40) |
|
|
|
256 | (1) |
|
Introduction to Assessment of Ventilation |
|
|
256 | (1) |
|
Alveolar Ventilation and Dead Space |
|
|
257 | (1) |
|
|
258 | (1) |
|
Alveolar Ventilation and Paco2 |
|
|
258 | (1) |
|
Best Index of Ventilation |
|
|
259 | (1) |
|
Factors Associated with Normal Ventilation |
|
|
259 | (1) |
|
Pressure Gradients in the Lung |
|
|
260 | (1) |
|
|
261 | (2) |
|
Dynamic Versus Static Compliance |
|
|
263 | (2) |
|
|
265 | (2) |
|
Surface Tension and the Lung |
|
|
267 | (1) |
|
Resistance to Ventilation |
|
|
268 | (3) |
|
Breath Sounds and Gas Flow |
|
|
271 | (1) |
|
|
272 | (2) |
|
Muscular Weakness and Fatigue |
|
|
274 | (1) |
|
|
274 | (1) |
|
Ventilatory Capacity Versus Ventilatory Demand |
|
|
274 | (2) |
|
Compliance and Resistance |
|
|
276 | (1) |
|
Ventilatory Muscle Weakness |
|
|
276 | (1) |
|
|
276 | (1) |
|
Risk Factors for Development of Ventilatory Failure |
|
|
277 | (2) |
|
Clinical Manifestations of Ventilatory Failure |
|
|
279 | (2) |
|
Indications for Mechanical Ventilatory Support |
|
|
281 | (1) |
|
|
281 | (1) |
|
Acute Ventilatory Failure |
|
|
281 | (1) |
|
Impending Ventilatory Failure |
|
|
282 | (1) |
|
Severe Oxygenation Problems |
|
|
282 | (1) |
|
Ventilator Discontinuance |
|
|
283 | (1) |
|
|
284 | (2) |
|
|
286 | (3) |
|
|
289 | (1) |
|
|
290 | (1) |
|
|
291 | (2) |
|
|
293 | (2) |
|
Chapter 8 Blood Gas Analysis, Hemoximetry, and Acid-Base Balance |
|
|
295 | (64) |
|
|
|
|
|
|
296 | (1) |
|
Introduction to Blood Gases and Acid-Base Balance |
|
|
296 | (1) |
|
|
296 | (1) |
|
Indications for Blood Gas Analysis |
|
|
297 | (1) |
|
Arterial Percutaneous Sampling |
|
|
297 | (4) |
|
Complications Associated with Arterial Punctures |
|
|
301 | (1) |
|
Arterialized Capillary Sampling |
|
|
302 | (1) |
|
Arterial Line Insertion and Sampling |
|
|
303 | (1) |
|
Indications for Radial Artery Cannulation |
|
|
303 | (1) |
|
|
304 | (1) |
|
Complications Associated with Arterial Cannulation |
|
|
305 | (1) |
|
Blood Pressure Monitoring |
|
|
305 | (1) |
|
|
305 | (2) |
|
Maintenance, Troubleshooting, and Removal of Radial Arterial Catheters |
|
|
307 | (1) |
|
Venous Blood Gas Sampling |
|
|
307 | (1) |
|
Indications for Mixed Venous or Central Venous Blood Gas Measurement |
|
|
307 | (1) |
|
Technique for Mixed Venous Blood Gas Sampling |
|
|
308 | (1) |
|
|
309 | (1) |
|
|
309 | (1) |
|
Errors in Blood Gas Analysis |
|
|
309 | (2) |
|
Quality Assurance and Control |
|
|
311 | (1) |
|
|
311 | (1) |
|
|
311 | (1) |
|
Brgnsted-Lowry Definitions |
|
|
311 | (1) |
|
Quantifying Hydrogen Ion Concentration |
|
|
312 | (1) |
|
Henderson Equation for Carbonic Acid |
|
|
312 | (1) |
|
Henderson-Hasselbalch Equation |
|
|
313 | (2) |
|
Calculation of Bicarbonate |
|
|
315 | (1) |
|
Regulation of Blood Acids |
|
|
315 | (2) |
|
|
317 | (1) |
|
|
317 | (1) |
|
Arterial Blood Gas Interpretation |
|
|
318 | (1) |
|
Assessment of Oxygenation |
|
|
319 | (1) |
|
Assessment of Ventilation |
|
|
319 | (1) |
|
Assessment of Acid-Base Balance |
|
|
320 | (1) |
|
Conventional Nomenclature for Blood Gas Interpretation |
|
|
321 | (1) |
|
Other Measures of the Metabolic Component of Acid-Base Balance |
|
|
322 | (3) |
|
Problems with Conventional Nomenclature |
|
|
325 | (2) |
|
Expected Respiratory and Renal Compensation |
|
|
327 | (1) |
|
Expected Maximal Compensation for Respiratory Disorders |
|
|
327 | (3) |
|
Expected Maximal Compensation for Metabolic Disorders |
|
|
330 | (4) |
|
Clinical Interpretation of Arterial Blood Gases |
|
|
334 | (1) |
|
Ventilatory Failure (Respiratory Acidosis) |
|
|
335 | (3) |
|
Alveolar Hyperventilation (Respiratory Alkalosis) |
|
|
338 | (2) |
|
|
340 | (6) |
|
|
346 | (3) |
|
Mixed and Combined Disorders |
|
|
349 | (3) |
|
|
352 | (1) |
|
|
353 | (1) |
|
|
353 | (1) |
|
|
354 | (1) |
|
|
355 | (1) |
|
|
355 | (1) |
|
|
356 | (3) |
|
Chapter 9 Laboratory Studies |
|
|
359 | (40) |
|
|
|
|
|
360 | (1) |
|
Introduction to the Diagnostic Laboratory |
|
|
360 | (1) |
|
|
360 | (1) |
|
|
361 | (1) |
|
Red Blood Cell Parameters |
|
|
361 | (1) |
|
Hemoglobin and Hematocrit |
|
|
361 | (1) |
|
|
362 | (1) |
|
Hematocrit and Other Indices |
|
|
362 | (2) |
|
White Blood Cell Parameters |
|
|
364 | (2) |
|
|
366 | (1) |
|
|
366 | (1) |
|
|
367 | (1) |
|
|
367 | (1) |
|
|
367 | (1) |
|
|
367 | (1) |
|
|
368 | (1) |
|
|
368 | (2) |
|
Carbohydrates: Diabetes Tests |
|
|
370 | (2) |
|
|
372 | (1) |
|
|
372 | (1) |
|
Lipids and Cardiac Markers |
|
|
373 | (1) |
|
|
374 | (1) |
|
Water and Electrolyte Balance |
|
|
374 | (2) |
|
Hormones and Therapeutic Drug Monitoring |
|
|
376 | (1) |
|
|
376 | (1) |
|
Specimens of the Lower Respiratory Tract |
|
|
376 | (5) |
|
|
381 | (3) |
|
|
384 | (1) |
|
Skin Testing for Tuberculosis or Fungi |
|
|
385 | (1) |
|
|
385 | (1) |
|
|
386 | (1) |
|
|
386 | (2) |
|
|
388 | (2) |
|
|
390 | (1) |
|
|
390 | (6) |
|
|
396 | (3) |
|
Chapter 10 Cardiac Assessment and the Electrocardiogram |
|
|
399 | (40) |
|
|
|
|
|
400 | (1) |
|
Introduction to the Electrocardiogram |
|
|
400 | (1) |
|
Overview of Cardiac Function |
|
|
400 | (2) |
|
|
402 | (2) |
|
|
404 | (2) |
|
Components of the ECG Tracing |
|
|
406 | (1) |
|
|
406 | (1) |
|
The PR Segment and Interval |
|
|
407 | (1) |
|
|
407 | (2) |
|
The ST Segment and T Wave |
|
|
409 | (1) |
|
Rhythm Strip Interpretation |
|
|
410 | (1) |
|
Step 1 Calculate and Evaluate the Heart Rate |
|
|
410 | (5) |
|
Step 2 Evaluate the Cardiac Rhythm |
|
|
415 | (3) |
|
Step 3 Assess the Strip for P Waves, PR Interval, and the Relationship of the P Waves to the QRS Complexes |
|
|
418 | (1) |
|
Step 4 Assess the QRS Complex |
|
|
419 | (1) |
|
Step 5 Inspect the ST Segment |
|
|
420 | (1) |
|
Step 6 Determine the QRS Axis |
|
|
420 | (1) |
|
Step 7 Overall Assessment |
|
|
420 | (2) |
|
|
422 | (1) |
|
|
422 | (3) |
|
Evolution of Myocardial Infarction |
|
|
425 | (1) |
|
|
426 | (1) |
|
|
427 | (1) |
|
Treatment of Heart Failure |
|
|
427 | (1) |
|
Management of Cardiac Arrhythmias |
|
|
427 | (1) |
|
|
427 | (1) |
|
Nonpharmacologic Treatment |
|
|
427 | (1) |
|
Rhythms Initiated in the Sinus Node |
|
|
428 | (2) |
|
Rhythms Initiated in the Atria |
|
|
430 | (1) |
|
Rhythms Initiated at the AV Junction |
|
|
430 | (1) |
|
Rhythms Initiated in the Ventricles |
|
|
431 | (2) |
|
Rhythms Initiated by Atrioventricular Blocks |
|
|
433 | (1) |
|
12-Lead ECG Interpretation |
|
|
434 | (1) |
|
Cardiovascular Complications ofCOVID-19 |
|
|
435 | (1) |
|
ECG for Diagnostic Purposes |
|
|
435 | (1) |
|
|
435 | (1) |
|
|
436 | (1) |
|
Other Diagnostic Tests and Procedures |
|
|
436 | (1) |
|
|
436 | (1) |
|
|
437 | (2) |
|
Chapter 11 Cardiopulmonary Imaging |
|
|
439 | (74) |
|
|
|
|
|
440 | (1) |
|
Introduction to Medical Imaging |
|
|
440 | (2) |
|
|
442 | (1) |
|
|
442 | (2) |
|
|
444 | (1) |
|
|
445 | (5) |
|
|
450 | (2) |
|
|
452 | (1) |
|
|
452 | (2) |
|
|
454 | (1) |
|
|
455 | (3) |
|
Diaphragm and Hemidiaphragms |
|
|
458 | (1) |
|
|
458 | (1) |
|
|
459 | (1) |
|
|
460 | (1) |
|
|
460 | (2) |
|
|
462 | (1) |
|
|
463 | (1) |
|
|
463 | (1) |
|
Magnetic Resonance Imaging |
|
|
463 | (1) |
|
|
464 | (1) |
|
|
464 | (1) |
|
|
465 | (1) |
|
Considerations in Transporting Critically III Patients |
|
|
465 | (1) |
|
|
466 | (1) |
|
|
466 | (1) |
|
Lung Ventilation and Perfusion Imaging |
|
|
466 | (1) |
|
PET Scans and Fusion Imaging |
|
|
467 | (1) |
|
|
467 | (1) |
|
Indications for PET and Fusion Imaging |
|
|
467 | (1) |
|
Limitations of Nuclear Medicine Scans |
|
|
468 | (1) |
|
Nuclear Medicine Cardiac Imaging |
|
|
468 | (1) |
|
|
468 | (2) |
|
|
470 | (1) |
|
Catheter-Directed Thrombolysis |
|
|
471 | (1) |
|
Percutaneous Abscess Drainage |
|
|
472 | (1) |
|
Radiation Exposure Considerations |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
472 | (1) |
|
|
473 | (1) |
|
|
474 | (1) |
|
|
474 | (1) |
|
|
475 | (3) |
|
|
478 | (5) |
|
Other Alveolar Airspace Disease |
|
|
483 | (1) |
|
|
483 | (1) |
|
Other Infectious Pulmonary Diseases |
|
|
484 | (3) |
|
Pulmonary Vascular Diseases |
|
|
487 | (3) |
|
Pneumothorax, Pneumomediastinum, and Hemothorax |
|
|
490 | (3) |
|
|
493 | (1) |
|
Interstitial Lung Disease |
|
|
494 | (3) |
|
|
497 | (1) |
|
Chronic Obstructive Pulmonary Disease |
|
|
497 | (3) |
|
Neoplastic Disorders of the Lung |
|
|
500 | (2) |
|
Miscellaneous Chest Conditions |
|
|
502 | (1) |
|
Placement of Chest Tubes and Lines and Endotracheal Tubes |
|
|
502 | (2) |
|
Imaging the Trauma Patient |
|
|
504 | (3) |
|
|
507 | (1) |
|
|
507 | (2) |
|
|
509 | (4) |
|
Chapter 12 Adult Pulmonary Function |
|
|
513 | (42) |
|
|
|
|
|
514 | (1) |
|
Introduction to Pulmonary Function Testing |
|
|
514 | (1) |
|
Purpose of Pulmonary Function Testing |
|
|
514 | (1) |
|
|
514 | (1) |
|
|
515 | (1) |
|
Factors That Influence Predicted Values |
|
|
515 | (1) |
|
Pulmonary Function Laboratory Equipment |
|
|
516 | (1) |
|
|
516 | (1) |
|
|
516 | (1) |
|
|
516 | (1) |
|
|
517 | (1) |
|
|
517 | (1) |
|
|
517 | (1) |
|
Measurements and Documentation |
|
|
517 | (1) |
|
|
517 | (1) |
|
|
518 | (1) |
|
|
518 | (1) |
|
|
518 | (2) |
|
|
520 | (1) |
|
|
520 | (1) |
|
Inspiratory Reserve Volume |
|
|
520 | (1) |
|
Expiratory Reserve Volume |
|
|
520 | (1) |
|
|
520 | (1) |
|
|
520 | (1) |
|
|
521 | (1) |
|
|
521 | (1) |
|
Functional Residual Capacity |
|
|
521 | (1) |
|
|
522 | (1) |
|
|
523 | (1) |
|
|
523 | (1) |
|
|
524 | (1) |
|
|
524 | (1) |
|
Forced Expiratory Volume in 1 Second |
|
|
524 | (1) |
|
Forced Expiratory Flow, Midexpiratory Phase |
|
|
525 | (1) |
|
|
525 | (1) |
|
|
525 | (1) |
|
|
526 | (1) |
|
Maximal Voluntary Ventilation |
|
|
527 | (1) |
|
Pre- and Postbronchodilator Pulmonary Function Testing |
|
|
527 | (1) |
|
|
528 | (1) |
|
Airway Resistance and Conductance |
|
|
529 | (1) |
|
Forced Oscillation Technique |
|
|
529 | (1) |
|
|
529 | (1) |
|
|
530 | (1) |
|
|
530 | (1) |
|
|
530 | (1) |
|
|
530 | (1) |
|
|
530 | (1) |
|
Cardiopulmonary Exercise Testing |
|
|
531 | (2) |
|
Bronchoprovocation Testing |
|
|
533 | (1) |
|
Pulmonary Function Testing in Children |
|
|
533 | (2) |
|
Pulmonary Function Test Interpretation |
|
|
535 | (1) |
|
|
535 | (1) |
|
|
536 | (9) |
|
Approach to Interpretation of Results |
|
|
545 | (6) |
|
|
551 | (1) |
|
|
551 | (1) |
|
|
552 | (3) |
|
Chapter 13 Bronchoscopy and Other Diagnostic Studies |
|
|
555 | (14) |
|
|
|
|
|
556 | (1) |
|
|
556 | (1) |
|
Clinical Indications for Bronchoscopy |
|
|
556 | (1) |
|
|
556 | (1) |
|
|
556 | (1) |
|
Masses and Solitary Pulmonary Nodules |
|
|
557 | (1) |
|
|
557 | (1) |
|
Interstitial Lung Disease |
|
|
557 | (1) |
|
|
557 | (1) |
|
|
558 | (6) |
|
|
564 | (1) |
|
|
564 | (1) |
|
|
565 | (1) |
|
Video-Assisted Thoracoscopic Surgery |
|
|
566 | (1) |
|
|
566 | (1) |
|
|
566 | (1) |
|
|
567 | (2) |
|
Chapter 14 Acute and Critical Care Monitoring and Assessment |
|
|
569 | (36) |
|
|
|
|
570 | (1) |
|
Introduction to Acute and Critical Care Monitoring and Assessment |
|
|
570 | (1) |
|
|
570 | (1) |
|
Monitoring Volume and Rate During Mechanical Ventilation |
|
|
571 | (1) |
|
Bedside Measures of Ventilation |
|
|
572 | (1) |
|
Assessment of Ventilation During Mechanical Ventilatory Support |
|
|
573 | (1) |
|
|
573 | (1) |
|
Inspiratory-to-Expiratory Ratio |
|
|
574 | (1) |
|
|
575 | (1) |
|
Assessment of the Intubated Patient Receiving Mechanical Ventilation |
|
|
576 | (2) |
|
|
578 | (1) |
|
Peak Inspiratory Pressure |
|
|
579 | (1) |
|
|
580 | (1) |
|
Pressure Control Ventilation and Pressure Support Ventilation |
|
|
580 | (4) |
|
PSV and PCV Flow and Pressure Waveforms |
|
|
584 | (2) |
|
Air Trapping and Auto-PEEP |
|
|
586 | (2) |
|
Pressure-Volume Curves and PEEP |
|
|
588 | (1) |
|
Monitoring the Patient Airway |
|
|
588 | (1) |
|
|
589 | (1) |
|
|
589 | (1) |
|
|
590 | (2) |
|
Transcutaneous Monitoring |
|
|
592 | (1) |
|
|
592 | (2) |
|
|
594 | (1) |
|
Electrocardiography Monitoring and Analysis |
|
|
594 | (1) |
|
|
595 | (6) |
|
Special Considerations for the Care and Monitoring of the COVID-19 Patient |
|
|
601 | (1) |
|
|
601 | (1) |
|
|
602 | (1) |
|
|
603 | (2) |
|
Chapter 15 Obstructive Sleep Apnea and Other Sleep-Related Breathing Disorders |
|
|
605 | (22) |
|
|
|
|
|
606 | (1) |
|
Introduction to Respiration in Sleep |
|
|
606 | (1) |
|
|
606 | (1) |
|
|
607 | (2) |
|
|
609 | (1) |
|
Spectrum of Breathing-Related Sleep Disorders |
|
|
609 | (1) |
|
Central Sleep Apnea Syndromes |
|
|
610 | (1) |
|
Obstructive Sleep Apnea Syndromes |
|
|
611 | (2) |
|
|
613 | (1) |
|
|
613 | (1) |
|
|
613 | (1) |
|
|
614 | (1) |
|
|
614 | (1) |
|
Polysomnography Diagnosis and Severity Classification |
|
|
615 | (1) |
|
Alternatives to Attended Nocturnal Polysomnography |
|
|
615 | (1) |
|
|
616 | (1) |
|
|
616 | (1) |
|
|
616 | (1) |
|
Positive Airway Pressure Devices |
|
|
616 | (4) |
|
|
620 | (1) |
|
|
621 | (1) |
|
|
621 | (1) |
|
|
622 | (1) |
|
|
623 | (1) |
|
|
623 | (4) |
|
Chapter 16 Neonatal and Pediatric Assessment |
|
|
627 | (36) |
|
|
|
|
|
|
628 | (1) |
|
Introduction to Neonatal/Pediatric Assessment |
|
|
628 | (1) |
|
|
628 | (1) |
|
History and Physical Examination of the Mother |
|
|
628 | (1) |
|
Confirmation of Gestational Age |
|
|
629 | (1) |
|
Screening and Diagnosis of Aneuploidy |
|
|
629 | (1) |
|
|
630 | (1) |
|
Assessment of Fetal Well-Being |
|
|
631 | (3) |
|
Assessment of the Newborn |
|
|
634 | (1) |
|
|
634 | (1) |
|
Assessment Following Delivery |
|
|
635 | (2) |
|
|
637 | (1) |
|
|
637 | (3) |
|
Cardiovascular Function and Heart Rate |
|
|
640 | (1) |
|
Critical Congenital Heart Disease Screening |
|
|
641 | (1) |
|
|
642 | (1) |
|
|
643 | (4) |
|
|
647 | (1) |
|
Musculoskeletal System Assessment |
|
|
647 | (1) |
|
|
647 | (1) |
|
Assessment of the Extremities |
|
|
647 | (1) |
|
|
648 | (3) |
|
Assessment of the Pediatric Patient |
|
|
651 | (1) |
|
|
651 | (1) |
|
|
652 | (1) |
|
|
652 | (1) |
|
|
652 | (1) |
|
|
653 | (1) |
|
|
654 | (2) |
|
|
656 | (1) |
|
|
657 | (1) |
|
|
657 | (1) |
|
Diagnostic Imaging and Laboratory Testing |
|
|
658 | (1) |
|
|
658 | (1) |
|
Pulmonary Function Testing and Blood Gases |
|
|
658 | (4) |
|
|
662 | (1) |
|
|
662 | (1) |
|
|
662 | (1) |
|
|
662 | (1) |
|
|
662 | (1) |
References |
|
663 | (4) |
Appendix A Patient Assessment and the National Board for Respiratory Care (NBRC) Examinations |
|
667 | (6) |
Appendix B Synopsis of Cardiopulmonary Disease |
|
673 | (48) |
Appendix C Abbreviations |
|
721 | (3) |
Glossary |
|
724 | (33) |
Index |
|
757 | |